Number of Participants Experiencing an Adverse Event (AE) and/or Serious Adverse Event (SAE) Within the Indicated Category From Baseline (Day 1) to last dose of eltrombopag/early withdrawal visit (up to 981 days) [clinicaltrials_resource:84cdaa243644fc3fdbeeb91de4048b31]
An AE is any untoward medical occurrence in a participant, temporally associated with the use of a medical product, whether or not related to the product. An SAE is any untoward medical occurrence that, at any dose, results in death, is life-threatening, requires hospitalization or its prolongation, results in disability/incapacity, is a congenital anomaly/birth defect, or is another event considered serious. A drug-related AE is any AE that was judged to have a relationship with the study medication by the investigator. The severity of an AE is based on the investigator's clinical judgment.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of Participants Experiencing an Adverse Event (AE) and/or Serious Adverse Event (SAE) Within the Indicated Category From Baseline (Day 1) to last dose of eltrombopag/early withdrawal visit (up to 981 days) [clinicaltrials_resource:84cdaa243644fc3fdbeeb91de4048b31]
An AE is any untoward medical occurrence in a participant, temporally associated with the use of a medical product, whether or not related to the product. An SAE is any untoward medical occurrence that, at any dose, results in death, is life-threatening, requires hospitalization or its prolongation, results in disability/incapacity, is a congenital anomaly/birth defect, or is another event considered serious. A drug-related AE is any AE that was judged to have a relationship with the study medication by the investigator. The severity of an AE is based on the investigator's clinical judgment.
Bio2RDF identifier
84cdaa243644fc3fdbeeb91de4048b31
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:84cdaa243644fc3fdbeeb91de4048b31
measure [clinicaltrials_vocabulary:measure]
Number of Participants Experie ...... Within the Indicated Category
time frame [clinicaltrials_vocabulary:time-frame]
From Baseline (Day 1) to last dose of eltrombopag/early withdrawal visit (up to 981 days)
description
An AE is any untoward medical ...... estigator's clinical judgment.
identifier
clinicaltrials_resource:84cdaa243644fc3fdbeeb91de4048b31
title
Number of Participants Experie ...... hdrawal visit (up to 981 days)
@en
type
label
Number of Participants Experie ...... daa243644fc3fdbeeb91de4048b31]
@en